Hong Jun Young, Lin Hening
Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, United States.
Department of Chemistry and Chemical Biology, Howard Hughes Medical Institute, Cornell University, Ithaca, NY, United States.
Front Pharmacol. 2021 Sep 28;12:735044. doi: 10.3389/fphar.2021.735044. eCollection 2021.
Sirtuins use NAD to remove various acyl groups from protein lysine residues. Through working on different substrate proteins, they display many biological functions, including regulation of cell proliferation, genome stability, metabolism, and cell migration. There are seven sirtuins in humans, SIRT1-7, each with unique enzymatic activities, regulatory mechanisms, subcellular localizations, and substrate scopes. They have been indicated in many human diseases, including cancer, neurodegeneration, microbial infection, metabolic and autoimmune diseases. Consequently, interests in development of sirtuin modulators have increased in the past decade. In this brief review, we specifically summarize genetic and pharmacological modulations of sirtuins in cancer, neurological, and cardiovascular diseases. We further anticipate this review will be helpful for scrutinizing the significance of sirtuins in the studied diseases.
沉默调节蛋白利用烟酰胺腺嘌呤二核苷酸(NAD)从蛋白质赖氨酸残基上去除各种酰基。通过作用于不同的底物蛋白,它们展现出许多生物学功能,包括调节细胞增殖、基因组稳定性、新陈代谢和细胞迁移。人类有七种沉默调节蛋白,即SIRT1 - 7,每种都具有独特的酶活性、调节机制、亚细胞定位和底物范围。它们已被证实与许多人类疾病有关,包括癌症、神经退行性疾病、微生物感染、代谢性疾病和自身免疫性疾病。因此,在过去十年中,人们对开发沉默调节蛋白调节剂的兴趣有所增加。在这篇简短的综述中,我们特别总结了沉默调节蛋白在癌症、神经和心血管疾病中的基因和药理学调节作用。我们进一步期望这篇综述将有助于审视沉默调节蛋白在所研究疾病中的重要性。